| Identification | Back Directory | [Name]
CHF-6523 | [CAS]
2500579-21-3 | [Synonyms]
CHF-6523 1H-2-Benzopyran-1-one, 3-[(1S)-1-[4-amino-3-(5-hydroxy-3-pyridinyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-4-[3-[(4-methyl-1-piperazinyl)methyl]phenyl]- | [Molecular Formula]
C33H32N8O3 | [MOL File]
2500579-21-3.mol | [Molecular Weight]
588.66 |
| Hazard Information | Back Directory | [Uses]
CHF-6523 is an orally active PI3Kδ inhibitor that can be used in research related to chronic obstructive pulmonary disease (COPD)[1]. | [IC 50]
PI3Kδ | [References]
[1] First-Time Drug Disclosures- 2024 EFMC-ISMC and ACS Fall |
|
|